指南与共识炎症性肠病

现代治疗时代急性重症溃疡性结肠炎的新诊断标准:REFINED-ASUC改良Delphi共识

New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by Refined Evaluation Framework and INvEstigations for Diagnostics in Acute Severe Ulcerative Colitis (REFINED-ASUC).
指南 / 共识 · Clin Gastroenterol Hepatol · 2026-07-22

该共识由欧洲、北美和亚太地区的消化内科专家通过4轮Delphi小组和共识会议制定,针对已接受门诊皮质类固醇或先进治疗的患者,提出了急性重症溃疡性结肠炎(ASUC)的新诊断标准,包括3项主要标准和至少2项次要标准,并指出内镜应确认诊断并排除巨细胞病毒感染。

要点

  • 已接受先进治疗或皮质类固醇的患者:3项主要标准(CRP≥2×ULN、24小时内排便≥6次、≥50%排便带肉眼血便)加至少2项次要标准可诊断ASUC。
  • 高剂量皮质类固醇患者需不同阈值:CRP≥1×ULN、≥33%排便带肉眼血便。
  • 内镜应确认ASUC诊断并排除巨细胞病毒感染,影像学应支持排除中毒性巨结肠。

核心结论

  • 该共识为现代治疗时代提供了ASUC的新诊断标准,可应用于已接受门诊治疗的患者,这些标准包含额外的临床和实验室参数,需在前瞻性研究中验证。

研究设计与样本

  • 欧洲、北美和亚太地区的消化内科医生参与了4轮Delphi小组和共识会议,成立了REFINED-ASUC工作组;共识定义为Likert量表≥70%同意/不同意,或单选/多选回答≥70%同质性。

主要发现

  • 专家小组同意当代实践需要ASUC诊断标准。
  • 对于接受先进治疗或皮质类固醇的患者,共识认为ASUC诊断可基于3项主要标准(CRP≥2×正常上限、24小时内排便≥6次、24小时内≥50%排便带肉眼血便)加至少2项次要标准(低白蛋白、心率增快、夜间排便、低血红蛋白、体温升高或白细胞计数升高)。
  • 对于高剂量皮质类固醇患者,构成需要不同阈值的亚组(CRP≥1×正常上限、24小时内≥33%排便带肉眼血便)。
  • 对于未治疗患者,同意类似原则但未达成共识。
  • 专家小组同意内镜应确认ASUC诊断并排除巨细胞病毒感染,影像学检查应支持排除中毒性巨结肠。

关键数值与推荐

  • 主要标准:CRP≥2×正常上限、24小时内排便≥6次、24小时内≥50%排便带肉眼血便。
  • 次要标准:低白蛋白、心率增快、夜间排便、低血红蛋白、体温升高或白细胞计数升高。
  • 高剂量皮质类固醇亚组阈值:CRP≥1×正常上限、24小时内≥33%排便带肉眼血便。

临床怎么用

  • 临床可依据该共识对已接受门诊皮质类固醇或先进治疗的患者进行ASUC诊断评估。
  • 内镜应作为确认ASUC诊断并排除巨细胞病毒感染的手段。
  • 影像学检查应支持排除中毒性巨结肠。

局限性

  • 这些标准需在前瞻性研究中验证。
  • 对于未治疗患者的类似原则未达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acute severe ulcerative colitis (ASUC) is a life-threatening manifestation of ulcerative colitis. The diagnosis typically relies on the 1955 Truelove and Witts criteria. These do not incorporate treatment history with steroids or modern advanced therapies. This Delphi panel gathered expert opinion regarding potential criteria and approaches for diagnosing ASUC in contemporary practice, including current outpatient treatment with corticosteroids or advanced therapy. METHODS: European, North American, and Asia-Pacific gastroenterologists participated in a 4-round Delphi panel and consensus meeting, forming the Refined Evaluation Framework and INvEstigations for Diagnostics in ASUC (REFINED-ASUC) Working Group. Consensus was defined as ≥70% agreement/disagreement for Likert scale, or ≥70% homogeneity for single/multiple choice responses. RESULTS: Panelists agreed there is an unmet need for ASUC criteria in contemporary practice. Consensus was obtained that an ASUC diagnosis could be based around 3 'major' criteria (C-reactive protein (CRP) ≥2× the upper limit of normal (ULN), ≥6 bowel movements in 24 hours, ≥50% bowel movements with visible blood in 24 hours) plus ≥2 'minor' criteria (low albumin, increased heart rate, nocturnal bowel movements, low hemoglobin, increased body temperature, or elevated leukocyte count) in patients treated with advanced therapy or corticosteroids. Patients on high-dose corticosteroids constitute a subgroup requiring different thresholds (CRP ≥1× upper limit of normal, ≥33% bowel movements with visible blood in 24 hours). Similar principles were agreed upon for untreated patients but without achieving consensus. Panelists agreed that endoscopy should confirm ASUC diagnosis and exclude cytomegalovirus infection and radiologic investigations should support excluding toxic megacolon. CONCLUSIONS: This consensus provides new diagnostic criteria for ASUC in the modern therapeutic era, which can be applied to patients already in receipt of outpatient treatments. These criteria include additional clinical and laboratory parameters for validation in prospective studies.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Raine T, Peyrin-Biroulet L, Begun J, et al. New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by Refined Evaluation Framework and INvEstigations for Diagnostics in Acute Severe Ulcerative Colitis (REFINED-ASUC). Clin Gastroenterol Hepatol. 2026. PMID: 42486394. doi:10.1016/j.cgh.2026.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。